Taiwan boasts one of the most progressive health systems in Asia, but the government currently faces a number of pressing policy challenges, including a rapidly ageing population and rising healthcare costs.
Healthcare providers, drug makers and medical device companies also face a challenging competitive environment in Taiwan, but one which also offers growth opportunities across the health spectrum.
For instance, the government’s active promotion of the biomedical industry, with the goal of becoming a regional hub for pharma R&D, is generating interest in Taiwan as an attractive location for clinical trials.
Also, the digital health trend has great potential to transform healthcare in Taiwan and is attracting the growing attention of companies operating at the intersection of technology and medical science.
This PwC report on Taiwan’s health industries provides a comprehensive introductory overview of the healthcare, biotechnology, pharmaceutical and medical device sectors, and is up to date as of June 2018.
For more insights about the Taiwan market, please contact our Health Industries Leader Lily Wong.
Tel: +886 2 27296666, x26703